Superworth

Zoetis price to book ratio ZTS

Market value divided by the book value of the company's net assets, since 2013.

Today, Nov 3, 2026
10.9×
10-year median
18.1×
Against its 10-year history
8th
percentile: 0 is its lowest day, 100 its highest
10-year range
9.1× to 26.4×
Peer median
4.9×

Zoetis' price to book ratio is 10.9× as of Nov 3, 2026.

That is below its ten-year median of 18.1×, lower than on 92% of days in the last ten years.

Over that time it ranged from 9.1× in Oct 2026 to 26.4× in Oct 2020.

The median for 10 healthcare stocks of a similar size is 4.9×.

Price to book ratio over time

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far10.9×9.1×16.6×
202510.3×9.7×16.3×
202414.2×13.4×18.1×
202317.8×14.7×19.5×
202214.6×13.4×21.3×
202124.7×18.4×24.7×
202021.8×17.7×26.4×
201923.7×19.2×25.4×
201819.2×17.7×23.4×
201717.6×16.7×19.3×
201616.7×15.3×22.6×
201519.4×15.7×20.5×
201416.2×13.4×19.3×
201319.4×18.2×23.9×

Against its peers

Companies in Healthcare nearest Zoetis' size, closest first, today.

CompanyPrice to book ratio
ZTSZoetis10.9×
ILMNIllumina12.6×
MTDMettler-Toledo Internationaln/m
RMDResMed4.9×
GEHCGE HealthCare Technologies3.3×
CNCCentene1.5×
BIIBBiogen2.0×
DXCMDexCom12.2×
RPRXRoyalty Pharma5.7×
LHLabcorp3.4×
ONCBeOne Medicines7.8×
Peer median4.9×

What the price to book ratio tells you

Market value divided by the accounting value of the company's net assets. Below 1 means the market values the business at less than what it owns on paper.

Book value misses brands, software and people, so asset-light companies always look expensive on it. Most useful for banks and industrials.

More on Zoetis

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.